AMLX — Amylyx Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapMomentum Trap

Annual balance sheet for Amylyx Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	96.1	347	371	177	317
Net Total Accounts Receivable
Net Total Receivables	—	15.3	40	0.447	0.088
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	105	382	465	189	324
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.474	8.13	6.41	2.73	5.49
Other Long Term Assets
Total Assets	106	391	517	194	333
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities	17.4	46.6	82	28.4	22.7
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	17.4	50.8	84	28.9	27.4
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	88.2	341	433	165	305
Total Liabilities & Shareholders' Equity	106	391	517	194	333
Total Common Shares Outstanding
Total Preferred Shares Outstanding